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ABSTRACT 
 Vagal Nerve Stimulation (VNS) has been shown to be a promising therapeutic 
technique in treating many neurological diseases, including epilepsy, stroke, traumatic 
brain injury, and migraine headache. The mechanisms by which VNS acts, however, are 
not fully understood but may involve changes in cerebral blood flow. The vagus nerve 
plays a significant role in the regulation of heart rate and cerebral blood flow that are altered 
during VNS. Here, the effects of acute vagal nerve stimulation using varying stimulation 
parameters on both heart rate and cerebral blood flow were examined. Laser Speckle 
Contrast Analysis (LASCA) was used to analyze the cerebral blood flow of male Long–
Evans rats. In the first experiment, results showed two distinct patterns of responses to 
0.8mA of stimulation whereby animals either experienced a mild or severe decrease in 
heart rate. Further, animals that displayed mild heart rate decreases showed an increase in 
cerebral blood flow that persisted beyond VNS. Animals that displayed severe decreases 
showed a transient decrease in cerebral blood flow followed by an increase that was greater 
than that observed in mild animals but progressively decreased after VNS. The results 
suggest two distinct patterns of changes in both heart rate and blood flow that may be 
related to the intensity of VNS. To investigate the effects of lower levels of stimulation, an 
additional group of animals were stimulated at 0.4mA. The results showed moderate 
changes in heart rate but no significant changes in cerebral blood flow in these animals. 
The results demonstrate that VNS alters both heart rate and cerebral blood flow and that 
these effects are dependent on current intensity. 
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BACKGROUND 
 
Neuromodulation, including non-invasive brain stimulation and cranial nerve 
stimulation, has become a promising therapeutic approach for the treatment of several 
neurological conditions. While the earliest known use of Vagal Nerve Stimulation (VNS) 
was in 1883, research into its mechanisms and possible uses are just beginning. The Food 
and Drug Administration (FDA) initially approved it for use in patients with epilepsy in 
1997. It has since been cleared by the FDA for use in depression, cluster headaches, and 
migraines, and number published articles exploring it per year have increased dramatically 
in recent years (3). 
The specific mechanisms by which VNS acts to treat these conditions are largely 
unknown. The right and left vagus nerves exit from the brainstem, and go through the neck 
(in the carotid sheath between the carotid artery and jugular vein), upper chest (along the 
trachea), lower chest and diaphragm (along the esophagus), and into the abdominal cavity 
(1). Additionally, in the brainstem, the sensory afferent fibers terminate in the nucleus 
tractus solitarius, which then sends fibers that connect directly or indirectly to different 
brain regions. These regions include the dorsal raphe nuclei, locus coeruleus, amygdala, 
hypothalamus, thalamus, and orbitofrontal cortex (2). The vagus nerve also interfaces with 
parasympathetic control of the heart, lungs, and digestive tract such that it regulates heart 
rate, blood pressure (3), the gag reflex and satiation following consumption of food (4). 
Animal studies have shown that VNS causes a number of physiological changes. 
For example, VNS modulated the dendritic cell profile by decreasing CD103+ dendritic 
cell population in the posthemorrhagic shock mesenteric lymph, which mediates the 
inflammatory response (5). It has also been shown to attenuate inflammatory response to 
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endotoxin (6), and macrophage activation (7). Vagal nerve stimulation has been used as a 
therapeutic technique for many diverse conditions and diseases. For stroke, it has been used 
to improve functional outcomes in rehabilitation (8-9) and also has been shown to reduce 
infarct size if stimulation is applied 30 minutes after a stroke for of 1 hour (10). VNS has 
most effectively been used to treat epilepsy (11-12) and depression (12-13).  Additionally, 
VNS has shown positive effects in the recovery of traumatic brain injury in humans (14). 
Studies in our own lab have suggested that VNS may enhance motor recovery and reduce 
infarct volume in an animal model of stroke (unpublished results). However, it did not 
seem to alleviate motor impairments in an animal model of Parkinson’s Disease 
(unpublished results). 
One potential mechanism by which VNS acts is by altering cerebral blood flow. 
According to previous studies, high and low levels of stimulation both increase and 
decrease cerebral blood flow in humans in certain regions of the brain (15-19). One study, 
though, found that standard VNS is less potent in modulating cerebral blood flow as 
microburst VNS (20). Decreases in the left and right lateral orbitofrontal cortex and left 
inferior temporal lobe and significant increases in the right dorsal anterior cingulate, left 
posterior limb of the internal capsule/medial putamen, the right superior temporal gyrus, 
and the left cerebellar body (21). In other studies, however, it was shown that VNS has 
induced inconsistent patterns of activation and deactivation. This inconsistency may reflect 
differences in the methods used to measure CBF measurement (SPECT or PET), the time 
point of measurement relative to the initiation of VNS and the kind of stimulation, (chronic, 
frequency, output current, stimulation time) (33). 
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The specific mechanisms by which the brain modulates cerebral blood flow are 
unclear, but several key mechanisms have been proposed (22). The brain has the ability to 
maintain relatively constant blood flow, known as autoregulation. Autoregulation occurs 
when cerebral perfusion pressure (CPP) is between 50 and 150 mmHg. A second 
mechanism that has been identified is flow-metabolism coupling, by which cerebral blood 
flow varies with cerebral metabolism. Several molecules have been shown to have an effect 
on neuronal activity in the context of the regulation of cerebral blood flow, namely 
potassium and hydrogen as a result of their involvement in synaptic transmission (22).  
The effect of vagal nerve stimulation on heart rate has also been researched 
extensively to help explain the mechanisms of the vagus nerve. VNS has been found to 
have the potential to effectively and rapidly to decrease heart rate, in acute settings (23-
24). In the context of VNS, heart rate is often analyzed by measuring heart rate variability. 
Heart rate variability has been shown to both increase and decrease depending on 
individual response as well as stimulation parameters, but no direct correlation has been 
found (25). It has also been shown that in dogs, stimulation of the right vagus caused a 
greater reduction in heart rate than stimulation of the left vagus (26). In the present study, 
we investigated how acute VNS alters cerebral blood flow and heart rate in rats. 
It is also important to make note of the effects of differing levels of stimulation 
already discovered in literature. When VNS has been used as a therapy for epilepsy, seizure 
frequency has been shown to increase at lower output currents (27). Additionally, it has 
been shown that different fibers of the vagus nerve respond differently to different types of 
stimulation, as vagal A-fibers have the lowest amplitude-duration threshold required for 
VNS to excite action potentials and B-fibers have higher excitation thresholds whereas the 
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highest excitation thresholds belong to the narrow, unmyelinated C-fibers (28). VNS. 
Increasing VNS intensity to resulted in tachycardia during the on-phase of VNS, and 
further dampened the sinus bradycardia with no change in average heart rate, and then 
eventually induced the expected bradycardia during the on-phase of VNS (29). Recent 
studies have shown that Reducing the current intensity and number of stimulations (Fast 
VNS) resulted in robust cortical plasticity, using 6 times fewer VNS pairings than the 
Standard protocol. However, reducing the current too much, under identical circumstances 
will insufficient in driving cortical plasticity (30, 31). 
MATERIALS AND METHODS 
Subjects 	
Nineteen adult (80+ days old) male Long–Evans hooded (330–500g) were used in 
the study Controls (n=9) and VNS (n=10). They were group housed (two animals/cage) in 
standard laboratory cages on a 12:12 hour light/dark cycle throughout the experiment. The 
animals were food restricted prior to surgery to ensure the appropriate response to 
isoflurane, xylazine, and ketamine. Rats were initially anesthetized via a 5% induction of 
isoflurane gas and maintained at 1.5%).  After cuff implantation, a craniotomy over the 
frontal cortex was made (-0.5-4.0mmAP; 0.0-4mmML Bregma) under xylazine (5mg/kg) 
and ketamine (100mg/kg) anesthesia. The dura was removed and the cisterna magna was 
punctured to alleviate edema. 
Cuff Implantation and Vagal Nerve Stimulation 	
Vagal Nerve Stimulation was applied via custom-made bipolar stimulating nerve 
(5-6 kOhms impedance) cuffs that were built in the Kleim Lab based on a protocol from 
the Kilgard Lab at University of Texas at Dallas. First, two strands of platinum iridium 
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wire were cut 7.5cm long and stripped on each end. Care was taken to ensure that just the 
necessary amount of bare wire was exposed, as extra bare wire could cause complications 
during stimulation. One end of each wire was then soldered into a gold pin and UV glue 
was added to cap the solder material and cured with UV light. Next, 3mm Micro-Renathane 
tubing with a diameter of 1.5mm was cut and an anterior cut was made into which the nerve 
would be placed. The PI wires with gold pins were then threaded through holes made in 
the tubing and the entire cuff was inspected under a microscope and UV glue was added 
where necessary to ensure that no bare wires were exposed. The cuffs were placed on the 
nerve in the opening that was made near the throat of the rat, as is shown below. The pins 
were left outside the rat and attached to the Isolated Pulse Stimulator. Stimulation consisted 
of a 500ms train of pulses at 30Hz. For the first experiment, each biphasic pulse was 0.8mA 
and 100µs in phase duration. For the second experiment, , each biphasic pulse was 0.4mA 
and 100µs in phase duration. 
 
Figure 1: Cuff Implanted On The Vagus Nerve 
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Figure 2: VNS Cuff (Left), VNS Cuff Design (Right) 
Laser Speckle Contrast Analysis (LASCA)  	
Prior to the experiment, a number of pilot animals were to tested to optimize the 
LASCA system. The camera used was a PeriCam PSI System by Perimed and had been 
previously used to determine large scale changes in blood flow observed after endothelin 
1 application to the frontal cortex.  We then tested it to see if it could be used to test subtler 
differences observed during VNS.  The PeriCam PSI System works by using Laser Speckle 
Contrast Analysis (LASCA) on a defined region of interest. LASCA visualizes tissue blood 
perfusion by illuminating the region of interest with laser light and collecting the resulting 
“speckle pattern” that is backscattered. This speckle pattern is sensitive even to blood flow 
movements, and can thus be used to measure blood perfusion. The PeriCam PSI System 
records the blood perfusion using the arbitrary units, Perfusion Units (PU) by measuring 
the speckle contrast, which is defined as the ratio between the standard deviation and mean 
of intensity. The camera was placed at approximately 10.0cm above the region of interest 
so that the entirety of the opened skull is within the region. 
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Figure 3: Perimed PSI System (right) and Example of LASCA Image (left) 
 
 
 
Figure 4: Perimed App Output, Including Blood Flow Graph (Top), Perfusion Image 
(Bottom Left), Intensity Image (Bottom Middle), Subject Photo (Bottom Right) 
Pilot Procedures 	
During a test surgery, several important parameters were analyzed and finalized. 
For one, it was determined whether or not cerebral blood flow could be adequately 
measured without fully exposing the brain. If this were the case, the subject could be kept 
under gas the entire surgery. It was discovered that this was not the case and, as a result, it 
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was decided to inject the subject with ketamine and xylazine to keep them anesthetized 
during the opening and measurement of cerebral blood flow. Additionally, the parameters 
of the PIMSoft software (distance of camera, size of region of interest, frame rate) were 
tested and analyzed as well as the practical functions of each directive option provided by 
the software. Once this was done, cerebral blood flow was measured on this test animal. 
To ensure that the blood flow was being adequately measured, an agent that causes blood 
flow to dramatically decrease, endothelin was placed onto the region of interest. The 
camera immediately registered a severe drop in blood flow, and the functionality was 
confirmed.  
Experimental Design 	
 
 
Figure 5: Vagal Nerve Stimulation Design; Experiment 1, Top (10 Minutes No 
Stimulation, 10 Minutes 0.8mA Stimulation (Black Bars), 10 Minutes No Stimulation), 
Experiment 2, Bottom (10 Minutes No Stimulation, 10 Minutes 0.4mA Stimulation, 10 
Minutes No Stimulation) 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
0.8mA	Stimulation
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
0.4mA	Stimulation
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While under, the vagus nerve was isolated by making an incision slightly left of 
midline and above the sternum. The vagus nerve was then isolated from the carotid artery 
in order to place the cuff around the nerve. After finding the nerve and ensuring that the 
correct nerve had been located, the cuff was implanted on the nerve and tested in three 
ways. Firstly, there had to be no error light on the stimulator, which would denote whether 
or not the current was actually passing through the electrode. Secondly, it was ensured that 
the electrode was not stimulating any other part of the body as it was noted that surrounding 
muscle tissue could be stimulated if the cuff was not placed properly. Finally, the heart rate 
was monitored using a small animal pulse oximeter and compared with the vagal nerve 
stimulation on and off.  After these tests were done, the cuff was secured in various ways: 
chiefly suturing, dental acrylic, and wex-cels. Some of these methods were discovered 
throughout the experimental process and will be discussed further in the discussion section.  
Following the craniotomy, the cuff was again tested to ensure that there was no 
error light, no unnecessary stimulation, and a significant drop in heart rate. Once each of 
these things were assured, the VNS was set in the “off” position, and the camera was placed 
over the brain so that the entirety of the “target” region included the exposed brain. This 
was done by making incremental movements of the camera until the entire region had 
either red or yellow pixels, which would later average out to a more defined image of the 
brain. Once this was completed, all the lights in the room were turned off and the recording 
button was pressed. Two groups were planned for Experiment 1. In the first group, ten 
minutes of data was collected with no stimulation, and then the VNS was turned on and 
ten more minutes of data were collected. Lastly, the VNS was turned off again and ten 
minutes of data were collected. In control animals, no stimulation was given for the entire 
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thirty-minute period. For Experiment 2, ten minutes of data was collected with no 
stimulation, and then the VNS was turned on at 0.4mA and ten more minutes of data were 
collected. This was again followed by 10 minutes of no stimulation and then the VNS was 
turned on again, this time at 0.8mA and ten minutes of data were collected. Throughout the 
recordings, both the heart rate and oxygen saturation levels were recorded every two 
minutes. Additionally, the initial drop in heart rate was noted at its minimum to keep track 
of the total initial drop. Any injection or disturbance throughout the thirty minutes was 
registered. Due to variability in both heart rate and blood flow, all measures were 
normalized to baseline (0-10 minutes).  
 
RESULTS 
 
Regular Current Intensity – 0.8mA Stimulation 
 
A Oneway Repeated measures ANOVA with Group as a between subject factor and 
Time as a within subject factor revealed a significant Group X Time interaction 
[F(14,238)=5.68; p<0.001) on relative cerebral blood flow. VNS animals had significantly 
lower mean blood flow measures compared to controls across minutes 10 through 11:40, 
normalized at minutes 12-14 and then significantly higher through minute 30 (Figure 7). A 
similar analysis conducted on heart rate showed a significant Group X Time interaction 
[F(14,38)=3.678; p<0.01) on heart rate. VNS animals showed a significant decrease in 
heart rate compared to controls immediately after VNS was turned on that remained lower 
until minute 24 (Figure 6). 
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It was noted that there were two very distinct responses in VNS rats. Half of the animals 
showed a severe drop in heart rate (60% or more; mean decrease of 148.4) and half showed 
a mild drop (20%; mean decrease of 56.8bpm). A subsequent analysis was conducted to 
analyze changes in cerebral blood flow and heart rate in these subsets of groups.  A 
significant Group X Time interaction [F(30,240)=15.197; p<0.001) was found for heart 
rate with the Severe VNS animals showing a significantly lower mean heart rate in 
comparison to both the controls and Mild VNS animals immediately after VNS onset that 
returned to Mild VNS levels through minutes 14-20. Heart rate levels then were 
significantly higher than both groups the duration of VNS. Mild animals were significantly 
lower than Controls until minute 28.  Further a significant Group X Time interaction 
[F(38,304)=9.19; p<0.01) was found for cerebral blood flow. Severe VNS animals showed 
a decrease in CBF as compared to both the Controls and Mild VNS animals immediately 
within the first 40 seconds after VNS was turned on (Figure 9). Cerebral blood flow then 
began to increase and stayed higher than control levels from minute 16 and then throughout 
the recording time. Mild VNS animals on the other hand showed a progressive increase in 
blood flow as compared Controls through minute 30. Thus two different patterns of 
cerebral blood flow were observed within the VNS animals that appeared to coincide with 
differences in the initial decrease in heart rate. 
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Figure  6: Heart Rate Averages for Control and Vagal Nerve Stimulation Groups 
 
Figure 7: Cerebral Blood Flow Averages for Control and Vagal Nerve Stimulation 
Groups 
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Figure 8: Heart Rate Averages for Control and Mild and Severe VNS Groups 
 
Figure 9: Cerebral Blood Flow Averages for Control, Mild, and Severe VNS Groups 
Reduced Current Intensity – 0.4mA Stimulation 	
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To examine the effects of reducing current intensity on the variable responses 
observed above, an additional group of animals was added. Stimulation again consisted of 
a 500ms train of pulses at 30Hz, but each biphasic pulse was now 0.4mA and 100µs in 
phase duration. A Oneway Repeated measures ANOVA with Group as a between subject 
factor and Time as a within subject factor revealed a significant Group X Time interaction 
[F(45,330)=3.53; p<0.001) on relative cerebral blood flow. Subsequent multiple 
comparisons (Fisher’s LSD) showed the 0.4mA animals did not significantly differ from 
Controls at any point but did differ from the Mild and Severe animals at the same time 
points (Figure 11).  A Oneway Repeated measures ANOVA with Group as a between 
subject factor and Time as a within subject factor revealed a significant Group X Time 
interaction [F(30,2200)=17.08; p<0.001) on relative heart rate. Subsequent multiple 
comparisons showed the 0.4mA animals did have significantly lower heart rates than the 
Controls and Mild animals at the immediate, 12,14,16 and minute time points (Figure 10) 
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Figure 10: Heart Rate Averages for Control, Mild, Severe VNS, 0.4 Stimulation Groups 
 
Figure 11: Cerebral Blood Flow Averages for Control, Mild, Severe VNS, 0.4 
Stimulation Groups 
DISCUSSION 
 
  The results of our experiments indicate that application of vagal nerve stimulation 
at 0.8mA results in two different patterns of acute changes in both cerebral blood flow and 
heart rate. All VNS animals showed an immediate decrease in heart rate that was limited 
to the duration of VNS and increases in cerebral blood flow that continued after VNS. 
Further, there were two different patterns of responses within the VNS animals. “Mild” 
animals showed a mild decrease in heart rate (20% decrease) while the “Severe” showed a 
severe decrease (60%).   In the case of the “mild” VNS group, these effects appeared to be 
prolonged even after VNS was switched off, and in the case of the “severe” VNS group, 
these effects appeared to revert back to the norm.  
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Exactly why there were two different types of response to VNS is unknown but 
may be related to issues with the electrode cuffs themselves leading to differences in their 
efficacy for driving the vagus nerve. The VNS cuffs were constructed according to a 
protocol provided by another lab researching VNS in rats. While this protocol appeared to 
be working properly, there were challenges. Specifically, the width of the cuff was too 
wide and could result in poor contact with the nerve. We changed to smaller in diameter 
cuffs, and the wires were stripped with far more precision, and the cuff was inspected 
thoroughly under a microscope and UV-Glue was applied when appropriate with surgical 
precision to ensure that there were no potential sources of error. Once they were implanted 
and tested, many of the cuffs had a propensity to fill with fluid and shift within the body 
during different times of transfer on the surgery table. As a result of this, there were times 
during the early experimentation when a cuff would no longer be working by the time it 
was necessary to apply the stimulation and measure blood flow. These animals were used 
as controls. The new cuff design helped to solve this problem to some degree, but the issue 
of fluid within the cuff may have reduced the charge density at the contact site. One way 
this was combatted was by placing absorption sponges, which were sectioned wex-cels, in 
and around the cuff. Additionally, dental acrylic was often used to seal the cuff to prevent 
fluid from entering. These methods were largely successful but there is the possibility that 
there were differences in how well the cuffs were driving the vagus nerve. This is one 
potential reason that we observed two different patterns of responses.   
If we assume that the differences in responses between the Mild and Severe groups 
were due to issues with electrode construction and therefore efficacy in stimulating the 
vagus nerve, then it is interesting to postulate how those differences may manifest as 
17	
changes in cerebral blood flow and heart rate. We hypothesize that VNS drives both the 
feedback systems that control heart rate and cerebral blood flow and that the responses of 
these systems varies as a function of how much stimulation is being delivered.  
The parasympathetic vagus nerve is made up of 80% afferent fibers and has major 
cardiac branches that allow the vagus nerve to send information to the brain and have some 
neural control of heart rate (23). It has been found that there is significant variance in the 
induced changes in heart rate. Some correlation has been found between frequency of 
stimulation and change in heart rate (32). If, we were delivering different stimulation 
intensities we may have been differentially driving the neural circuitry regulating heart rate 
and cerebral blood flow.   
Studies measuring cerebral blood flow in relation to VNS have had varied results 
throughout the years. In early studies, it was found the VNS increased rCBF in the 
brainstem, hypothalami, thalami, and insular cortices and decreased rCBF bilaterally in the 
hippocampus, amygdala and POC (15). As has been noted, though, other studies have 
shown that VNS has induced inconsistent patterns of activation and deactivation. This 
inconsistency was decided to be the result of many possible factors: the technique of rCBF 
measurement (SPECT or PET), the time point of measurement relative to the initiation of 
VNS and the kind of stimulation, which could be acute, chronic, frequency, output current, 
stimulation time) (33). In our experiment, many of these factors were kept consistent: the 
VNS was always acute, stimulation time was kept exactly consistent, and output current 
was not altered during experimentation. During each procedure, the cuff would be tested 
after implantation and the heart rate would be observed. During some procedures, a rat 
would show a drop in heart rate that was consistent with the “severe” VNS, but by the time 
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the rat was ready for CBF measurements, the VNS induced would only be consistent with 
the “mild” VNS parameters. The reason for the change, then, can only be ascribed to the 
changes in contact during transfer. This change could have resulted in less consistent 
frequency measures or dampened stimulation that would result in a change in cerebral 
blood flow. This is supported by the findings of Henry et al., who found differing responses 
of different brain areas to high and low stimulation levels (15). 
Another question is related to the blood flow measurements in the “severe” VNS 
group. After the initial severe drop in CBF and heart rate, the blood flow spiked up to above 
the control value and eventually dropped down again to a value that was closer to the 
original value of perfusion. It is possible that this is due to the autoregulation of the brain, 
which is able to occur within certain cerebral pressures. It seems possible that the extreme 
change in CBF and heart rate prompted the autoregulation to be more acutely activated.  
Another source of difficulty during the implantation of the cuff was the bundle of 
nerves of which the vagus nerve is a part. It was discovered that there were always several 
nerves that ran alongside the vagus nerve that could have drastically different effects on 
the body. At times, both the vagus nerve and another one of the nerves in the bundle could 
be stimulated simultaneously, and in other cases, the wrong nerve was stimulated 
altogether. After this was realized, this was accounted for in future surgeries 
All of these changes can be possibly explained by referring to the anatomy of the 
vagus nerve and its connections in both the brain and the heart, briefly described in Figure 
13. Vagal nerve stimulation directly stimulates two of the pathways: the pathway between 
the heart and the dorsal motor nucleus of the vagus nerve (DMV) and nucleus ambiguous 
(NA) and the pathway between the nucleus tractus solitaries (NTS) and the baroreceptors. 
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These are both a part of the loop that regulates heart rate. This is connected to the regulation 
of cerebral blood flow by way of the caudal ventrolateral medulla (CVLM), which connects 
to the rostral ventrolateral medulla (RVLM), which is part of the loop that regulates 
cerebral blood flow by informing the dilation of blood vessels (BV) which connects to the 
trigeminal ganglion, which increases cerebral blood flow. It is clear that some stimulation 
has a distinct effect on heart rate, and that this stimulation also affects the cerebral blood 
flow. It is our hypothesis that the feedback loop that plays a significant role in the regulation 
of cerebral blood flow, including the trigeminal ganglia and rostral ventrolateral medulla, 
is only activated when the stimulation is significant enough to warrant autoregulation of 
cerebral blood flow. In the case of the severe stimulation, there is an initial drop in heart 
rate and blood flow. Then the blood flow spikes for a time before returning slowly returning 
to more normal levels, normalizing completely when VNS is turned off. This correlation 
between dramatic decrease in heart rate and an equally dramatic drop in cerebral blood 
flow is clearly related. This dramatic change and higher stimulation results in the activation 
of the feedback loop, resulting in an attempt by the brain to return to previous levels. 
Because the autoregulation feedback loop has been activated, by way of the NTS-CVLM-
RVLM connection, it remains primed when VNS is switched off, and CBF is able to return 
back to normal levels. In the case of the mild VNS, the heart rate drop is not significant 
enough to result in a change in cerebral blood flow, and the stimulation is not enough to 
activate the feedback loop. As a result, the VNS results in a bump in cerebral blood flow, 
and this increase is sustained because the autoregulation feedback loop has not been 
activated. 
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Figure 12: Potential Role of the Vagus Nerve in Modulating Cerebral Blood Flow and 
Heart Rate. RVLM: Rostral Ventrolateral Medulla, CVLM: Caudal Ventrolateral 
Medulla, DMV: Dorsal Motor Nucleus of the Vagus Nerve, NA: Nucleus Ambiguous, 
NTS: Nucleus Tractus Solitaries, BV: Blood Vessels 
The results of the lower levels of stimulation were equally interesting. It is clear 
that there is a significant difference in cerebral blood flow in response to differing levels 
of vagal nerve stimulation. This is clear when comparing the 0.4mA data to the previously 
collected 0.8mA data. A change in cerebral blood flow still occurs under lower stimulation 
parameters, but this change is altogether different from both previously determined “mild” 
and “severe” VNS groups that occurred as a result of stimulation at 0.8mA. The difference 
is also evidenced by comparing cerebral blood flow in the same animal at two different 
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time points stimulating at differing levels. When a subject receives the 0.4mA level of 
stimulation, the response is shown statistically to be unique to the cerebral blood flow 
response when that same subject is later stimulated at 0.8mA. The exact responses are not 
always consistent—in fact, differences in age of the animal, effects of injected drugs, and 
efficacy of the cuff seal have all shown potential to affect the responses to the differing 
levels of stimulation. 
It is still clear, though, that this small change in stimulation results in a drastic 
change in the response of cerebral blood flow to vagal nerve stimulation. This alteration of 
CBF response could have significant therapeutic consequences, as the brain is reacting in 
a significantly different way even within the same animal. More research is needed to 
discover what changes have the largest impact, and what considerations need to be taken 
to result in the most beneficial therapeutic parameters for vagal nerve stimulation. 
 
 
 
 
 
 
REFERENCES 
 
[1] S. E. Krahl, “Vagus nerve stimulation for epilepsy: A review of the peripheral 
mechanisms,” Surg Neurol Int, vol. 3, no. Suppl 1, pp. S47–S52, Jan. 2012. 
 
[2] R. H. Howland, “Vagus Nerve Stimulation,” Curr Behav Neurosci Rep, vol. 1, no. 2, 
pp. 64–73, Jun. 2014. 
 
22	
[3] D. A. Groves and V. J. Brown, “Vagal nerve stimulation: a review of its applications 
and potential mechanisms that mediate its clinical effects,” Neurosci Biobehav Rev, vol. 
29, no. 3, pp. 493–500, May 2005. 
 
[4] H.-R. Berthoud, “The vagus nerve, food intake and obesity,” Regul Pept, vol. 149, no. 
1–3, pp. 15–25, Aug. 2008. 
 
[5] K. Morishita, T. W. Costantini, B. Eliceiri, V. Bansal, and R. Coimbra, “Vagal nerve 
stimulation modulates the dendritic cell profile in posthemorrhagic shock mesenteric 
lymph,” J Trauma Acute Care Surg, vol. 76, no. 3, pp. 610–617; discussion 617-618, 
Mar. 2014. 
 
[6] L. V. Borovikova et al., “Vagus nerve stimulation attenuates the systemic 
inflammatory response to endotoxin,” Nature, vol. 405, no. 6785, pp. 458–462, May 
2000. 
 
[7]W. J. de Jonge et al., “Stimulation of the vagus nerve attenuates macrophage 
activation by activating the Jak2-STAT3 signaling pathway,” Nat. Immunol., vol. 6, no. 
8, pp. 844–851, Aug. 2005. 
 
[8] N. Khodaparast et al., “Vagus nerve stimulation during rehabilitative training 
improves forelimb strength following ischemic stroke,” Neurobiol. Dis., vol. 60, pp. 80–
88, Dec. 2013. 
 
[9] S. A. Hays et al., “The timing and amount of vagus nerve stimulation during 
rehabilitative training affect poststroke recovery of forelimb strength,” Neuroreport, vol. 
25, no. 9, pp. 676–682, Jun. 2014. 
 
[10] “Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia: An 
unlikely role for cerebral blood flow.” [Online]. Available: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293221/. [Accessed: 12-Apr-2018]. 
 
[11] K. Vonck, P. Boon, M. D’Havé, T. Vandekerckhove, S. O’Connor, and J. De Reuck, 
“Long-term results of vagus nerve stimulation in refractory epilepsy,” Seizure, vol. 8, no. 
6, pp. 328–334, Sep. 1999. 
 
[12] A. H. Milby, C. H. Halpern, and G. H. Baltuch, “Vagus nerve stimulation for 
epilepsy and depression,” Neurotherapeutics, vol. 5, no. 1, pp. 75–85, Jan. 2008. 
[13] K. J. Ressler and H. S. Mayberg, “Targeting abnormal neural circuits in mood and 
anxiety disorders: from the laboratory to the clinic,” Nat Neurosci, vol. 10, no. 9, pp. 
1116–1124, Sep. 2007. 
 
[14] C. Shi, S. R. Flanagan, and U. Samadani, “Vagus nerve stimulation to augment 
recovery from severe traumatic brain injury impeding consciousness: a prospective pilot 
clinical trial,” Neurol. Res., vol. 35, no. 3, pp. 263–276, Apr. 2013. 
23	
 
[15] T. R. Henry et al., “Brain blood flow alterations induced by therapeutic vagus nerve 
stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation,” 
Epilepsia, vol. 39, no. 9, pp. 983–990, Sep. 1998. 
 
[16] T. R. Henry, R. A. E. Bakay, P. B. Pennell, C. M. Epstein, and J. R. Votaw, “Brain 
blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: 
II. prolonged effects at high and low levels of stimulation,” Epilepsia, vol. 45, no. 9, pp. 
1064–1070, Sep. 2004. 
 
[17] T. R. Henry et al., “Acute blood flow changes and efficacy of vagus nerve 
stimulation in partial epilepsy,” Neurology, vol. 52, no. 6, pp. 1166–1173, Apr. 1999. 
 
[18] K. V. Laere, K. Vonck, P. Boon, J. Versijpt, and R. Dierckx, “Perfusion SPECT 
Changes After Acute and Chronic Vagus Nerve Stimulation in Relation to Prestimulus 
Condition and Long-Term Clinical Efficacy,” J Nucl Med, vol. 43, no. 6, pp. 733–744, 
Jun. 2002. 
 
[19] M. Kosel, H. Brockmann, C. Frick, A. Zobel, and T. E. Schlaepfer, “Chronic vagus 
nerve stimulation for treatment-resistant depression increases regional cerebral blood 
flow in the dorsolateral prefrontal cortex,” Psychiatry Res, vol. 191, no. 3, pp. 153–159, 
Mar. 2011. 
 
[20] V. Martlé et al., “Regional brain perfusion changes during standard and microburst 
vagus nerve stimulation in dogs,” Epilepsy Res., vol. 108, no. 4, pp. 616–622, May 2014. 
 
[21] C. R. Conway et al., “Brain Blood-flow Change with Acute Vagus Nerve 
Stimulation in Treatment-Refractory Major Depressive Disorder,” Brain Stimul, vol. 5, 
no. 2, pp. 163–171, Apr. 2012. 
 
[22] E. C. Peterson, Z. Wang, and G. Britz, “Regulation of Cerebral Blood Flow,” Int J 
Vasc Med, vol. 2011, 2011. 
 
[23] Buschman Hendrik P., Storm Corstiaan J., Duncker Dirk J., Verdouw Pieter D., van 
der Aa Hans E., and van der Kemp Peter, “Heart Rate Control Via Vagus Nerve 
Stimulation,” Neuromodulation: Technology at the Neural Interface, vol. 9, no. 3, pp. 
214–220, Jul. 2006. 
 
[24] Y. Wang and G. Li, “[Effect of vagal nerve stimulation on heart rate and heart rate 
variability in the toads],” Zhongguo Ying Yong Sheng Li Xue Za Zhi, vol. 26, no. 2, pp. 
229–232, May 2010. 
 
[25] M. G. Frei and I. Osorio, “Left vagus nerve stimulation with the neurocybernetic 
prosthesis has complex effects on heart rate and on its variability in humans,” Epilepsia, 
vol. 42, no. 8, pp. 1007–1016, Aug. 2001. 
24	
 
[26] W. C. Randall and J. L. Ardell, “Selective parasympathectomy of automatic and 
conductile tissues of the canine heart,” Am. J. Physiol., vol. 248, no. 1 Pt 2, pp. H61-68, 
Jan. 1985. 
 
[27] C. Szabó, F. Salinas, A. Papanastassiou, J. Begnaud, M. Ravan, K. Eggleston, R. 
Shade, C. Lutz, and M. D. L. Garza, “High-frequency burst vagal nerve simulation 
therapy in a natural primate model of genetic generalized epilepsy,” Epilepsy Research, 
vol. 138, pp. 46–52, 2017. Ruffoli a, Filippo S. Giorgi b, Chiara Pizzanelli b, Luigi Murri 
b, Antonio Paparelli a, Francesco Fornai a,c,*  
 
[28] R. Ruffoli, F. S. Giorgi, C. Pizzanelli, L. Murri, A. Paparelli, and F. Fornai, “The 
chemical neuroanatomy of vagus nerve stimulation,” Journal of Chemical Neuroanatomy, 
vol. 42, no. 4, pp. 288–296, 2011. 
 
[29] J. L. Ardell, H. Nier, M. Hammer, E. M. Southerland, C. L. Ardell, E. Beaumont, B. 
H. Kenknight, and J. A. Armour, “Defining the neural fulcrum for chronic vagus nerve 
stimulation: implications for integrated cardiac control,” The Journal of Physiology, vol. 
595, no. 22, pp. 6887–6903, 2017. 
 
[30]	K. W. Loerwald, E. P. Buell, M. S. Borland, R. L. Rennaker, S. A. Hays, and M. P. 
Kilgard, “Varying Stimulation Parameters to Improve Cortical Plasticity Generated by 
VNS-tone Pairing,” Neuroscience, vol. 388, pp. 239–247, 2018. 
 
[31]	K. W. Loerwald, M. S. Borland, R. L. Rennaker, S. A. Hays, and M. P. Kilgard, 
“The interaction of pulse width and current intensity on the extent of cortical plasticity 
evoked by vagus nerve stimulation,” Brain Stimulation, vol. 11, no. 2, pp. 271–277, 
2018. 
 
[32] B. H. Neely and F. Urthaler, “Quantitative effects of sympathetic and vagal nerve 
stimulations on sinus and AV junctional rhythms,” Journal of the Autonomic Nervous 
System, vol. 37, no. 2, pp. 109–120, Feb. 1992. 
 
[33] A. Barnes, R. Duncan, J. A. Chisholm, K. Lindsay, J. Patterson, and D. Wyper, 
“Investigation into the mechanisms of vagus nerve stimulation for the treatment of 
intractable epilepsy, using 99mTc-HMPAO SPET brain images,” Eur. J. Nucl. Med. Mol. 
Imaging, vol. 30, no. 2, pp. 301–305, Feb. 2003. 
 
